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Abstract. Centractin (Arpl), an actin-related protein, 
is a component of the dynactin complex. To investigate 
potential functions of the protein, we used transient 
transfections to overexpress centractin in mammalian 
cells. We observed that the overexpressed polypeptide 
formed filamentous structures that were significantly 
longer and more variable in length than those observed 
in the native dynactin complex. The centractin fila- 
ments were distinct from conventional actin in subunit 
composition and pharmacology as demonstrated by the 
absence of immunoreactivity of these filaments with an 
actin-specific antibody, by resistance to treatment with 
the drug cytochalasin D, and by the inability to bind 
phalloidin. We examined the transfected cells for evi- 
dence of specific associations of the novel centractin fil- 
aments with cellular organelles or cytoskeletal proteins. 
Using immunocytochemistry we observed the colocal- 
ization of Golgi marker proteins with the centractin 
polymers. Additional immunocytochemical analysis us- 
ing antibodies to non-erythroid spectrin (fodrin) and 
Golgi-spectrin ([3IE*) revealed that spectrin colocal- 
ized with the centractin filaments in transfected cells. 
Biochemical assays demonstrated that spectrin was 
present in dynactin-enriched cellular fractions, was 
coimmunoprecipitated from rat brain cytosol using an- 
tibodies to dynactin subunits, and was coeluted with dy- 
nactin using affinity chromatography. Immunoprecipi- 
tations and affinity chromatography also revealed that 
actin is not a bona fide component of dynactin. Our re- 
suits indicate that spectrin is associated with the dynac- 
tin complex. We suggest a model in which dynactin as- 
sociates with the Golgi through an interaction between 
the centractin filament of the dynactin complex and a 
spectrin-linked cytoskeletal network. 
C 
ENTRACTIN is  an actin-related protein  (Arp) 1 that 
has been defined as a member of the Arpl class 
(Frankel et al., 1994; Fyrberg et al., 1994; Schroer 
et  al.,  1994).  Actin-related  proteins  share  30-62%  se- 
quence identity with conventional actin and are predicted 
to  have  similar  core  structures  for  nucleotide  binding 
(Kabsch and Holmes, 1995; Kelleher et al., 1995). The ac- 
tin-related proteins have been grouped into three classes 
(Schroer et al.,  1994),  however, the  extent of the actin- 
related protein family is not yet clear. To date, over 20 ac- 
tin-related proteins have been identified in eukaryotes; an 
actin-related  protein  in  protists  has  also  been  reported 
(Guerrero et al., 1995). The actin-related proteins appear 
to have important, but diverse cellular functions. Arpl null 
mutants in S. cerevisiae  have defects in nuclear migration 
and mitotic spindle orientation (Clark and Meyer, 1994; 
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Muhua et al., 1994). In filamentous fungi, nuclear distribu- 
tion is also affected by Arpl disruption (Plamman et al., 
1994; Robb et al.,  1995; Xiang et al.,  1994; Tinsley et al., 
1996; Bruno et al.,  1996).  Actin-related proteins 2 and 3 
have been demonstrated to be essential in S. cerevisiae and 
S. pombe, respectively (Schwob and Martin, 1992; Harata 
et al., 1994; Lees-Miller et al., 1992b).  In Acanthamoeba, 
Arps 2 and 3 are subunits of an 8.5-S oligomeric profilin- 
binding complex which localizes to the filopodia and cell 
cortex (Mullins, 1996; Kelleher et al., 1995; Machesky et 
al.,  1994). The  most  divergent  actin-related  proteins, 
Act3p  from S.  cerevisiae  and  Arpl3E  from Drosophila, 
have been localized to the nucleus and may play a role in 
chromatin packaging (Weber et al., 1995). 
Centractin (Arp 1), named for its apparent localization 
to the centrosome, was the first actin-related protein iden- 
tified in vertebrates (Lees-Miller et al.,  1992a; Clark and 
Meyer, 1992). Centractin has been found exclusively as a 
subunit of a 20-S macromolecular complex, dynactin, that 
consists  of  at  least  seven  different polypeptides  (Lees- 
Miller et al., 1992a; Paschal et al., 1993; Schafer et al., 1994; 
Tokito et al.,  1996).  Ultra-structural analysis of dynactin 
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decoration  revealed  that  centractin forms  a  37-nm  fila- 
ment of 8  to  13 monomers at the  base  of the complex, 
which resembles a short actin filament (Schafer et al., 1994). 
The actin capping protein, CapZ, and the p62 subunit of 
dynactin were localized to opposite ends of the centractin 
filament. The p150  Gtued subunit of dynactin binds to micro- 
tubules and extends from the 37-nm centractin filament 
to form a 24-nm sidearm (Waterman-Storer et al.,  1995; 
Schafer et al., 1994). The location of the p50 subunit within 
the complex remains to be determined and other potential 
components are still being characterized. 
Dynactin copurifies with the microtubule-based motor 
cytoplasmic dynein in preparations from numerous sources 
(Collins and Vallee, 1989; Steuer et al., 1990; Holzbaur et al., 
1991; Gill et al., 1991). Genetic studies have revealed that 
cytoplasmic dynein and  dynactin are  involved in similar 
cellular processes  (Plamman  et  al.,  1994;  Muhua  et  al., 
1994;  Eschel et al.,  1993;  Li et al.,  1993;  McGrail et al., 
1995; Clark and Meyer, 1994; Robb et al., 1995)  and bio- 
chemical evidence indicates that the intermediate chain of 
dynein binds directly to the p150  Glued subunit of dynactin 
(Karki and Holzbaur, 1995; Vaughan and Vallee, 1995). 
Cytoplasmic dynein has been implicated in the mainte- 
nance of the perinuclear localization of the Golgi (Cour- 
thesy-Theulaz et al., 1992), in the transport of lysosomes 
and endocytic vesicles (Lin and Collins, 1992; Aniento et al., 
1993), and in the retrograde transport of organelles along 
the  axon  (Schnapp  and  Reese,  1989;  Hirokawa  et  al., 
1990).  Dynein and dynactin are also involved in the pro- 
cesses of mitosis and nuclear migration (Vaisberg et al., 
1993; Eshel et al., 1993; Li et al., 1993; Muhua et al., 1994; 
Plamann et al.,  1994; Xiang et al.,  1994;  Saunders et al., 
1995; Yeh et al.,  1995; Robb et al., 1995; Echeverri et al., 
1996).  While the role of cytoplasmic dynein is clearly to 
generate force, the details of the specific role of dynactin 
in these processes remains to be resolved. The dynactin 
complex has been shown to be required for cytoplasmic 
dynein-mediated organelle motility along microtubules in 
an in vitro assay (Gill et al., 1991), and antibodies that in- 
hibit  the  dynactin/dynein  interaction  block  fast  axonal 
transport of organelles in extruded squid axoplasm (Wa- 
terman-Storer, C.M., S. Kvznetsov, S. Karki, D. Weiss, G. 
Langford, E.L.F. Holzbaur, manuscript submitted for publi- 
cation). 
Although dynactin and dynein have been demonstrated 
to be involved in disparate membrane-associated cellular 
processes, the nature of the interaction of these proteins 
with the membrane is not yet clear. Both dynein and dy- 
nactin may be isolated from membrane-associated as well 
as soluble cellular fractions (Gill et al., 1991; Holzbaur et al., 
1991; Lacey and Haimo, 1992; Tokito et al.,  1996).  Cyto- 
plasmic dynein and dynactin have been shown to copurify 
with Golgi-derived membrane fractions (Fath et al., 1994). 
Immunoeytochemistry with  antibodies  raised  to the  dy- 
nactin  subunits  p150  Glued, centractin,  and  p50  yields  a 
punctate vesicular staining of the cell, suggesting the asso- 
ciation of dynactin with membranous vesicles (Gill et al., 
1991; Clark and Meyer, 1992; Paschal et al.,  1993; Fath et 
al.,  1994; Echeverri et al.,  1996).  The association with the 
membrane appears to be peripheral (Gill et al.,  1991; Yu 
et al.,  1992; Fath et al.,  1994), yet no membrane receptor 
or  mechanism  to  tether  dynactin  and/or  dynein  to  the 
membrane has been identified. 
In this study we used cellular and biochemical analyses 
to address questions regarding the nature and function of 
the actin-related protein, centractin. With transfection as- 
says, we demonstrate that overexpression of centractin in 
mammalian cells results in the assembly of novel filaments. 
These filaments have morphological and pharmacological 
properties distinct from F-actin. Affinity chromatography 
and immunoprecipitations reveal that conventional actin 
is not a component of the dynactin complex. Coprecipita- 
tion assays demonstrate that spectrin and adducin associ- 
ate with the dynactin complex. In transfected cells, cen- 
tractin is associated with Golgi membrane structures and 
Golgi-spectrin (13IE*). Our  results  suggest  a  mechanism 
for attachment of the dynactin complex to the Golgi or- 
ganelle. We propose that the 37-nm centractin filament, 
which resembles the short actin mini-filaments associated 
with the spectrin-membrane network of erythrocyte cells, 
incorporates  into  an  organelle-spectrin  cytoskeleton  to 
tether dynactin to the membrane. In this manner, in con- 
junction with dynein, dynactin may perform a role in or- 
ganelle sorting and trafficking. 
Materials and Methods 
Antibody Production 
Polyclonal rabbit antibodies were raised against centractin and p150  at"~d, 
expressed as fusion proteins in E.  coli using the pET system (Novagen, 
Madison, WI). The centractin antibody UP385 (rabbit) was raised against 
a bacterially expressed fragment of the human cDNA clone correspond- 
ing to amino acids 3 to 376 (Waterman-Storer et al., 1995; and this study). 
UP454 (rabbit) and UPGP21 (guinea pig) anti-centractin antibodies were 
raised against amino acids 216 to 376. The anti-p150  cl"ed antibody UP235 
(rabbit) was raised against amino acids 39-1325 of the rat polypeptide (Holz- 
baur et al., 1991). These antibodies were affinity purified against the re- 
spective antigen immobilized on a CH-Sepharose 4B matrix (Pharmacia 
LKB Biotechnology, Piscataway, NJ). The centractin and actin antibodies 
used in this study were probed against purified actin, purified centractin, 
and cellular extract fractions to ensure that the antibodies to centractin 
(UPGP21, UP454, and UP385) and actin (C4) did not cross-react (see Fig. 1). 
A monoclonal antibody to 58K, a resident Golgi protein, was a gener- 
ous gift from Dr. George Bloom, University of Texas Southwestern, Dal- 
las, TX (Bloom and Brashear, 1989). A polyclonal antibody to chicken red 
blood cell spectrin, MH-1 9B, was a generous gift from Dr. Elizabeth Re- 
pasky, Roswell Park Cancer Institute, Buffalo, NY (Black et al., 1988). A 
monoclonal antibody, VIIIC7, to 13I~I spectrin was a generous gift from 
Drs. Prasad Devarajan and Jon Morrow (Yale University, New Haven, CT) 
(Harris et al., 1986). A polyclonal antibody raised against canine erythro- 
cyte spectrin, which recognizes [3I~* Golgi-spectrin was a generous gift 
from Drs.  Kenneth Beck  (Stanford University, Stanford, CA)  and W. 
James Nelson (Beck et al., 1994). A polyclonal antibody to a-adducin was 
a  generous gift from Dr. Vann Bennett. All other antibodies were ob- 
tained from commercial suppliers: mouse monoclonal antibodies to a-fodrin 
(clone AA6; ICN Biomedicals, Costa Mesa, CA), 13-COP (M3A5; Sigma 
Chem. Co., St. Louis, MO), ~/-adaptin  (Robinson and Kreis, 1992; A100/3; 
Sigma) and actin (Cao et al., 1993; clone C4; Boehringer Mannheim Corp., 
Indianapolis, IN) and a rat monoclonal antibody to tubulin (clone YL1/2; 
Serotec, Washington, DC). 
Cell Culture,  Transient Transfections, 
Immunocytochemistry, and Drug Treatment 
Mammalian PtK2 cells were maintained in E-MEM supplemented with 
2 mM glutamine, 10% heat-treated FCS, 100 U/ml penicillin and 100 p.g/ml 
streptomycin, and were split twice weekly using trypsin-EDTA (Gibco 
LTI, Grand Island, NY). Cells were transiently transfected by the calcium 
phosphate precipitation method (Sambrook et al., 1989) with a construct 
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tein samples were resolved on a  10%  SDS-PAGE  gel,  electro- 
blotted to  Immobilon, and the blot  was  (a)  Coomassie stained. 
(Lane 1) Actin purified from acetone powder; (lane 2) recombi- 
nant centractin purified from E. coli; (lane 3), a  high salt extract 
of taxol-stabilized microtubules prepared from rat brain cytosol. 
(b) Corresponding immunoblot of a  probed with the monoclonal 
antibody to actin, C4. (c) Corresponding immunoblot of a probed 
with a  polyclonal antibody to centractin, UP454. The second im- 
munogenic band in c (lane 2) is a breakdown product of recombi- 
nant centractin. Note that the two antibodies, C4 and UP454, are 
not only specific for purified proteins, but are specific in recogni- 
tion  of the respective proteins within a  cellular  extract fraction 
(lane 3). The centractin specific antibodies, UP385 and UPGP21, 
also used in this study, show no cross-reactivity with actin  (not 
shown). 
(pcC) of the human cDNA encoding centractin cloned into pcDNA3 vector 
(Invitrogen, San Diego, CA) in which expression is under the control of 
the human cytomegalovirus promoter. After transfection, cells were fixed 
at time points ranging from 18 to 24 h after washout using either -20°C 
MeOH with 1 mM EGTA or at 37°C for 5 min in 2% formaldehyde/1% Tri- 
ton-X 100 (in MES buffer: 0.1 M MES, 1 mM MgCI2, 1 mM EGTA, 0.05 
mM EDTA, 4% PEGe~00, pH 6.75), followed by 5 min in 0.125% glutaral- 
dehyde in MES, 5 rain in MES, 5 min in 2% formaldehyde in MES, and fi- 
nally two 5-rain changes in NaBH4/PBS. The slides were rinsed in PBS 
and blocked in 5%  goat serum containing 1%  BSA and 0.05%  sodium 
azide in PBS, pH 7.4. For some experiments the cells were placed on ice 
for 1-2 h before fixation as noted. 
The fixed cells were assayed by immunofluorescence with primary anti- 
bodies as noted, either at 4°C overnight or at 30°C for 2 h. Fluorescein- 
labeled goat anti-mouse and donkey anti-rabbit and/or Texas red-labeled 
donkey  anti-rabbit  and  donkey  anti-guinea  pig  secondary antibodies 
were used to detect the primary antibodies, Slides were mounted using 
Mowial 4-88  (Calbiochem Corp.,  La  Jolla,  CA),  viewed using  a  Leica 
DMRB  epifluorescence microscope and  100  x  objective (0.6  NA) with 
FITC  and Texas red filters, and photographed using a  Leica photoau- 
tomat system. In all epifluorescence double-labeled immunocytochemis- 
try  experiments, the primary antibody to  centractin was followed with 
Texas red labeling and the primary antibody for the other protein of inter- 
est  was  assayed  using  fluorescein  labeling.  This  procedure  eliminates 
bleed-through of the centractin signal from one channel to the other (ex- 
perimental controls reviewed but not shown). 
Cytosol Preparation and Immunoprecipitations 
Cytosol was prepared by rinsing frozen rat brains in cold 0.9% saline to 
wash away blood vessels followed by rinsing in PHEM (50 mM Pipes, 50 
mM Hepes, 1 mM EDTA, 2 mM MgC12, pH 6.9).  Ice cold PHEM buffer 
containing leupeptin (10  p.g/ml),  pepstatin (1  Ixg/ml), n-tosyl-L-arginine 
methylester  (10  vg/ml)  and  1  mM  phenylmethylsulfonyl fluoride  was 
added to the brain tissue at a 1:1 (wt/vol) ratio. The tissue was Dounce ho- 
mogenized and the resulting homogenate was clarified by centrifugation 
at 39,000  g  for 30  rain at 4°C.  The supernatant was further clarified at 
100,000 g for 1 h to obtain cytosol. For immunoprecipitations, 1 ml of a re- 
suspended slurry of protein A  agarose beads  (GIBCO-BRL,  Gaithers- 
burg, MD) was washed in phosphate-buffered saline (PBS, pH 7.4). Anti- 
bodies to  either centractin  (UP454)  or p150  ch'~d (UP235)  were  loaded 
onto the protein A agarose in separate tubes, rocked overnight at 4°C, and 
then washed in PBS to remove any unbound antibody. Cytosol was pre- 
adsorbed with protein A  agarose without antibody for 30 rain at 4°C be- 
fore incubation with antibody-bound beads. The two tubes with antibody 
(UP454 and UP235) and control protein A  agarose beads without anti- 
body were incubated with equal amounts of cytosol with rocking at 4°C 
for 3 h and then washed extensively in nondenaturing 1×  RIPA (50 mM 
Tris-HCl, pH 7.5,  150 mM NaCI, 1.0% NP-40, 0.5% deoxycholate). The 
protein A  beads were boiled in sample buffer (Laemmli, 1970)  and the 
eluted samples were analyzed by SDS-PAGE and immunoblotting. 
A TP Extract of  Microtubules and Sucrose Gradients 
An ATP extract of microtubules was prepared from cytosol (described 
above) according to the method of Paschal et al.  (1991).  The resulting 
ATP extract from the rnicrotubule affinity preparation was then loaded 
onto a 5-20% sucrose gradient and centrifuged at 150,000 g  for 16 h  at 
4°C. The gradient was then fractionated into 1-ml fractions and analyzed 
by SDS-PAGE followed by Western blotting. 
Affinity Chromatography 
Cytosol was prepared as described above. The dynein intermediate chain 
(DIC) affinity beads and the BSA control beads were prepared as de- 
scribed in Karki and Holzbaur (1995).  Briefly, 1 ml of rat brain cytosol 
was loaded onto an affinity column with a bed volume of 0.4 ml of packed 
beads and washed with 2 column volumes of 50 mM NaCI in HEM (50 mM 
Hepes, 1 mM EDTA, 2 mM MgCI2, pH 6.9), followed by 18 column vol- 
umes of HEM. The beads were eluted with 1 M NaCI in HEM. The pro- 
teins in each sample were precipitated with TCA, resuspended in gel sam- 
ple buffer and analyzed by SDS-PAGE and Western blotting. 
SDS-PAGE and lmmunoblotting 
Gel  samples  were  resolved  by  electrophoresis  through  SDS-PAGE 
(Laemmli, 1970) and electroblotted onto Immobilon-P membranes (Milli- 
pore Corp., Bedford, MA). After Coomassie Brilliant blue staining, the 
blots were blocked using 5% nonfat milk in Tris-buffered saline, pH 8.0, 
with 0.05%  Tween-20 and 0.05%  sodium azide and incubated with pri- 
mary antibodies overnight at 4°C. Detection was accomplished by means 
of horseradish pernxidase (Jackson Immunoreseareh Labs, West Grove, 
PA) and Renaissance Western blot chemiluminescence reagent (Dupont 
New England Nuclear, Boston, MA). 
Results 
Overexpression  of Centractin Results in the 
Formation of  Novel Filaments That Do Not Colocalize 
with Actin or Microtubules 
To investigate the intracellular role of centractin, we be- 
gan our analysis using transient transfection assays. Tran- 
sient transfection assays allowed us to create a  system in 
which we could increase the concentration of centractin 
above normally low cellular levels (c~-centractin has been 
estimated to represent 0.006%  of total protein in  HeLa 
cells; Clark et al., 1994), in the presence of any interacting 
proteins and folding machinery. Transfection assays have 
been a powerful tool in the study of other cytoskeletal pro- 
teins  such  as  in  the  analysis  of  functional  differences 
among actin isoforms in mouse myoblasts and cardiomyo- 
cytes (Schevzov et al.,  1992; Lloyd et al., 1992; Lloyd and 
Gunning, 1993; von-Arx, 1995) and in the characterization 
of  the  pharmacology,  self-association,  and  nucleation 
characteristics of ~/-tubulin  (Shu and Joshi, 1995). 
Mammalian PtK2 cells were transiently transfected with 
a construct in which expression of the human cDNA en- 
coding centractin (pcC) is regulated by a strong promoter 
(CMV). Immunoblot analysis of the transfected cell lysate 
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(data not shown).  The transfection frequencies observed 
in these experiments ranged from 20%  to 79%  as deter- 
mined by direct counting of numerous fields of immuno- 
stained cells. 
In untransfected cells, centractin is localized to punctate 
vesicular structures as well as to the centrosome (Fig. 2 a; and 
see Clark and Meyer,  1992).  In transfected cells overex- 
pressing centractin, we observed novel filamentous struc- 
tures which reacted strongly with affinity-purified antibod- 
ies  to  centractin.  The  filamentous  structures  ranged  in 
length from ~0.63  Ixm to ~22  txm. Two distinct patterns 
were consistently observed: cells with centractin filaments 
localized  throughout  the  cytoplasm  (Fig.  2  c),  and  cells 
with  a  more perinuclear  accumulation of centractin  fila- 
ments (Fig. 2 b). The perinuclear filaments appeared to be 
highly three dimensional in structure, as confirmed by se- 
rial optical sectioning using  a  confocal microscope (data 
not shown). In some transfected cells the filaments formed 
a  weblike  structure  (Fig.  7  g)  and  in  other  transfected 
cells we observed single strands of centractin overlying the 
nucleus or adjacent to the nucleus (Fig. 5 a). REF52 and 
NIH3T3 cells were also transfected with the pcC construct, 
and identical results were observed. Cells transfected with 
the  vector  alone  displayed  normal  punctate  vesicular 
staining of centractin  indistinguishable  from that seen in 
untransfected cells. 
We  performed double-label  immunofluorescence  with 
antibodies  to  either  of the  cytoskeletal  proteins  tubulin 
(YL1/2) or actin (C4) along with antibodies to centractin 
(UP385 or UP454).  In both untransfected and transfected 
cells, centractin did not colocalize with microtubules (Fig. 3). 
This is in contrast to the observations made from transfec- 
tion assays of the p150  Glued component of the dynactin com- 
plex,  which  contains  a  microtubule-binding  domain  and 
binds to  microtubules in  vitro and  when overexpressed in 
transfected cells (Waterman-Storer et al., 1995). 
Although  the predicted protein sequences of actin and 
centractin share ~50%  identity (Clark and. Meyer, 1992), 
antibodies  we  have  raised  to centractin  (UP385,  UP454, 
and UPGP21) and a commercial pan-actin monoclonal an- 
tibody (C4) were observed to not cross-react as assessed 
by immunoblots (Fig.  1),  or by immunocytochemistry in 
untransfected  cells.  Our  immunofluorescence  data  indi- 
cate that in transfected ceils, overexpressed centractin was 
not incorporated into conventional actin filaments and ac- 
tin  was  not  incorporated  into  the  novel  centractin  fila- 
ments (Fig. 4, a and b). 
Figure 2.  Epifluorescence micrographs of cultured PtK2 cells over- 
expressing centractin.  Cells were transfected with a plasmid en- 
coding human centractin  and stained with the centractin-specific 
polyclonal antibody UP385. (a) Untransfected  cells reveal centro- 
somal staining as well as punctate staining indicative of vesicular 
association.  Immunocytochemistry of transfected cells revealed 
two major phenotypes: (b)  highly three  dimensional  extended 
structures,  mainly perinuclear in origin and (c) short centractin 
filaments  distributed  throughout the cytoplasm.  Centractin-spe- 
cific antibodies  UP454 and UPGP21, showed similar results. Bar, 
2 ~M. 
Pharmacological Properties of Centractin Polymers Are 
Distinct from Actin 
Two characteristic properties of conventional actin are the 
tight binding of phalloidin to F-actin and the disruption of 
actin filaments by cytochalasin D  (for review see Cooper, 
1987).  To compare these properties of conventional actin 
with those of centractin, we treated cells with phalloidin 
or with cytochalasin D, followed by immunocytochemical 
analysis. 
Phalloidin staining was performed three ways to prevent 
any competition between the centractin antibody and phal- 
loidin: (1) transfected cells were incubated with phalloidin 
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micrographs  demonstrating 
that  overexpressed  centrac- 
tin  and microtubules  do not 
colocalize. Cells were fixed in 
1 mM EGTA in MeOH and 
examined  by  epifluores- 
cence microscopy using dou- 
ble-label  immunocytochem- 
istry  with  affinity-purified 
anti-oentractin antibody, UF385 
(a and c), and a tubulin-spe- 
cific  rat  monoclonal  anti- 
body, YL1/2 (b and d).  Un- 
transfected  PtK2  cells  are 
shown  in a  and  b  and cells 
transfected  with  a  cDNA 
construct  encoding  centrac- 
tin are shown in c and d. Bar, 
3 p~M. 
before incubation with the anti-centractin antibody, UP385; 
(2) transfected cells were stained with phalloidin only; and 
(3) phalloidin and UP385 were mixed in solution together 
and then added to the coverslips. In all three protocols, 
while conventional actin filament staining was observed, in 
no case were the centractin filaments observed to label with 
rhodamine or FITC-conjugated phaUoidin (Fig. 4, c and d). 
To analyze the effect of cytochalasin D  upon the cen- 
tractin filaments in transfected cells, we treated the cells 
with  a  2-1~M solution for 30 min.  While  cytochalasin D 
treatment resulted in the complete disruption of the actin 
cytoskeleton,  the  centractin  filaments  remained  unaf- 
fected (Fig. 4, e-h). In further experiments, following a 30- 
min incubation with cytochalasin D, the cells were washed 
and incubated in fresh medium to allow for actin stress fi- 
ber regeneration. The cells were fixed at 0.5-, 1-, 2-, 3-, and 
24-h time points after treatment with cytochalasin D  and 
assayed with the anti-centractin antibody UP385 and with 
fluorescein-labeled phalloidin.  In  these  regeneration ex- 
periments centractin was not incorporated into stress fi- 
bers (data not shown). Our results suggest that centractin 
and  actin  have  different  pharmacological  and  dynamic 
properties and that centractin and actin do not copolymer- 
ize even under conditions where the actin cytoskeleton is 
disrupted and allowed to reform at a relatively high cellu- 
lar concentration of centractin. 
Golgi Membrane Markers Colocalize with the Novel 
Centractin Filaments 
Dynactin has been shown to copurify along with cytoplas- 
mic dynein in Golgi-derived membrane fractions (Fath et al., 
1994)  and  immunocytochemistry using  antibodies  raised 
against the dynactin subunits p1506rued, centractin, and p50 
yields a punctate vesicular staining of the cell, implying an 
association of dynactin with membranous vesicles (Gill et al., 
1991; Clark and Meyer, 1992; Paschal et al., 1993; Fath et al., 
1994; Echeverri et al.,  1996). In addition, dynactin can be 
immunoprecipitated  from  both  soluble  and  membrane 
fractions (Tokito et al., 1996). These results and our obser- 
vations of the often perinuclear localization of centractin 
observed in  transfected cells  led  us  to  perform double- 
label immunocytochemistry using antibodies to Golgi pro- 
teins and centractin. 
Antibodies to 58K, a resident Golgi protein (Bloom and 
Brashear, 1989), to ~/-adaptin (Robinson and Kreis, 1992) 
and to 13-COP (Allen and Kreis, 1986), were used to visu- 
alize the Golgi. Using the anti-13-COP antibody, a reticu- 
lar perinuclear staining pattern typical of Golgi was  ob- 
served, in  addition  to the expected 13-COP staining of a 
population  of vesicles  throughout  the  cytoplasm in  un- 
transfected cells.  The anti-58K and ~-adaptin antibodies 
also revealed an intact Golgi apparatus in untransfected 
cells.  In  transfected cells,  the  antibodies  to  all  three  of 
these Golgi-specific proteins produced a  staining pattern 
coincident with the localization observed with antibodies 
to centractin. In these transfected cells the Golgi staining 
pattern lacked the characteristic perinuclear punctate ap- 
pearance  observed  in  untransfected  cells  and  appeared 
highly disrupted  (Fig.  5).  In  some  transfected ceils,  the 
Golgi proteins that we used as markers colocalized with 
centractin filaments distributed throughout the cytoplasm 
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the colocalization with centractin was mainly perinuclear 
(Fig. 5 b). 
We investigated  the  effect of cold  treatment  and  no- 
codozole  on the  cells by incubation  of the  cells with  or 
without 33 p~M nocodozole at 4°C for 1-2 h. Interestingly, 
upon cold treatment (in the  absence or presence of no- 
codozole)  the  centractin  structures  became  thinner  and 
more extended than was observed at 37°C (Fig. 5 e). This 
effect was reversible upon shifting the temperature from 
4°C  back  to  37°C  before  fixation.  Double  immunocy- 
tochemical analysis using antibodies to the 58K Golgi resi- 
dent protein and to centractin revealed an apparent disso- 
ciation  of  the  Golgi  from  the  cold-treated  cytoplasmic 
centractin filaments in transfected cells (Fig.  5/3-  While 
the exact mechanism for this dissociation is unknown, this 
observation eliminates the possibility that the integrity of 
the centractin filament is dependent on an association with 
tubulovesicutar membranes which might act as a template 
for the formation of centractin polymers. This result also 
excludes the possibility that centractin associates with the 
Golgi only because it is being retained by this organelle. 
We are currently using electron microscopy to determine 
the  structure  and  composition  of  these  centractin  fila- 
ments  at  a  higher  resolution  (Holleran,  E.A.,  G.  Gray- 
board, L.D. Peachey, and E.L.F. Holzbaur, manuscript in 
preparation). 
Non-erythroid Spectrin and Golgi-Spectrin (El,Y*) 
Colocalize with Centractin Filaments 
Structural and primary sequence comparisons of centrac- 
tin with conventional actin predict the conservation of sur- 
face residues that are known to be involved in interactions 
of actin with several actin-binding  proteins  (reviewed in 
MuUins et al., 1996). The spectrin super-family binding site 
which has been identified in actin (reviewed in Hartwig, 1994; 
Matsudaira, 1994) is well-conserved in centractin (Fig. 6). 
We used a rabbit polyclonal antibody to IME* Golgi-spe- 
cific spectrin (Beck et al., 1994) and a mouse monoclonal 
antibody to a  broad range of non-erythroid spectrin iso- 
forms, AA6, to perform double-label immunocytochemis- 
try in transfected cells to assay for an association between 
spectrin and centractin. While untransfected cells showed 
a  perinuclear  punctate  localization  of  Golgi-spectrin 
(13I~*)  that  corresponded  to  a  punctate  centractin  pat- 
tern, in transfected cells the  Golgi-specific spectrin colo- 
calized  with  the  centractin  filaments  (Fig.  7,  c-f).  The 
transfected cells double-labeled with non-erythroid spec- 
trin and centractin revealed that in addition to the endoge- 
nous spectrin localization, spectrin was observed to colo- 
calize with the novel centractin filaments (Fig. 7, g and h). 
These unique structures which reacted with a monoclonal 
antibody to spectrin were absent from control slides of un- 
transfected cells. Our results indicate that while actin and 
tubulin  do not  colocalize with  the  novel centractin  fila- 
ments  observed  in  transfected  cells,  Golgi-spectrin  and 
Golgi proteins do, suggesting a  close cellular association 
between the centractin filaments, spectrin, and the Golgi. 
Spectrin Is Present in Dynactin-enriched 
Cellular Fractions 
The  immunocytochemical  results  described  above  sug- 
gested a potential association of spectrin with dynactin. We 
therefore examined cellular fractions in which the dynac- 
tin complex is enriched by probing a high salt extract and 
an ATP extract of taxol-stabilized microtubules prepared 
from rat brain cytosol with antibodies to spectrin (Fig. 8, a 
and b). We observed that spectrin i~ present within these 
dynactin-enriched fractions, using both a monoclonal anti- 
body (AA6) which recognizes a-fodrin (a-spectrin) and a 
polyclonal antibody (MH-1 9B) raised against chicken red 
blood cell spectrin (Fig. 8 b, lanes 3 and 4). 
The dynactin complex sediments at 20 S when loaded 
onto a 5-20% sucrose gradient (Holzbaur et al., 1991; Gill 
et al., 1991).  We investigated further if there was any spec- 
trin present in the 20-S dynactin-enriched sucrose fraction. 
We fractionated an ATP-extract of microtubules on a su- 
crose gradient and analyzed the fractions by immunoblot 
using antibodies to centractin and spectrin. While the peak 
of dynactin was found in fractions 4 and 5 and the peak of 
spectrin  was  found  at  a  lower  S  value  in  fractions  6-8, 
there  was  a  significant  amount  of spectrin  which  comi- 
grated with the dynactin complex (Fig. 8, c and d). 
The Dynactin Complex and 
Spectrin Coimmunoprecipitate 
To examine the possibility of a direct interaction between 
centractin filaments and spectrin, we performed immuno- 
precipitations from rat brain cytosol using affinity-purified 
antibodies to centractin and to p150  clued. These immuno- 
precipitations were performed under nondenaturing con- 
ditions which have been previously demonstrated to result 
in the coprecipitation of the subunit  polypeptides of dy- 
nactin (Tokito et al., 1996).  As a control for nonspecific in- 
teractions, cytosol was also incubated with protein A  aga- 
rose in the absence of antibodies; these beads were washed 
and eluted in parallel with the antibody-bound beads. 
Analysis of the resulting protein samples by Coomassie 
blue protein staining and by immunoblotting with antibod- 
Figure 4.  Centractin in transfected cells does not colocalize with the actin cytoskeleton and is morphologically  and pharmacologically 
distinct from actin. (a-h) Cells were fixed in formaldehyde with Triton X-100 and glutaraldehyde  and examined by epifluorescence  mi- 
croscopy using double-label immunocytochemistry.  (a and b) Transfected cells double-labeled  with the centractin-specific  antibody, 
UP454 (a) and a monoclonal actin-specific antibody, C4 (b). (c and d) Fluorescein-labeled  phalloidin  (final concentration of 0.005 U/p~l) 
was mixed with anti-centractin  antibody, UP385 (Molecular  Probes, Inc.) and placed on the coverslips for 1 h at room temperature. 
UP385 staining of centractin in a transfected cell (c) and the same cell stained with fluorescein-labeled  phalloidin (d). (e-h) Transfected 
PtK2 cells were treated with a final concentration of 2 ixM cytochalasin D for 30 min at 37°C (Bonder and Mooseker, 1986) before per- 
meabilization  and fixation and examined by double-label immunocytochemistry.  The cells were processed using UP385 (e and g) and 
FITC-phalloidin (fand h). Under conditions where actin filaments were completely disrupted (g and h), the novel centractin filaments 
remained intact (e and g). Bar, 5 IxM. 
Holleran et al. Cellular  Association  of Dynactin and Spectrin  1821 Figure 5.  Epifiuorescence micrographs demonstrating the colocalization of centractin filaments with the Golgi in transfected cells. 
(a-d) After MeOH fixation, transfected cells were labeled with anti-centractin antibody, UP385 (a, c, and e) and antibodies to Golgi 
marker proteins 13-COP (b) and 58K (d and f). The Golgi is disrupted, thicker and less punctate and follows the centractin pattern, indi- 
cating disruption of this organelle from its normal configuration and recruitment to novel centractin filaments in transfected cells, in 
contrast to the morphology observed in untransfected cells (arrow). (e and 3') Cells were treated at 4°C for 1 h before fixation. Upon im- 
munocytochemical analysis using antibodies to centractin and 58K, centractin was observed to form highly extended, thinner filaments 
that were mainly dissociated from the Golgi. Although we do not know the mechanism, this result suggests that the integrity of the cen- 
tractin filaments in transfected cells is independent of an association with tubulovesicular  membranes, and the association of centractin 
with the Golgi is not due to retention of excess polypeptide in the organelle. Bar, 5 I~M. 
les [o  centracun ano to  pIDO  .....  aemonstra[eta [nat  the 
dynactin complex  was  immunoprecipitated with  either 
antibody (Fig. 9). We then probed the immunoblots  with a 
monoclonal antibody to spectrin (clone AA6). As shown 
in Fig. 9 b lanes 3 and 4, significant immunoreactivity  with 
spectrin was observed in the immunoprecipitated dynac- 
un, out not in me control precipitate l rlg. Y O, lane z). we 
then probed the immunoblots with an antibody to addu- 
cin, and observed that this polypeptide also coimmunopre- 
cipitated with dynactin (Fig. 9 b, lanes 3 and 4). In contrast, 
conventional actin remained in the cytosol and was absent 
from immunoprecipitations  performed with antibodies di- 
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Figure 6.  The spectrin-binding  site in conventional  actin is conserved in centractin. The binding site for spectrin and related family mem- 
bers overlays subdomains 1 and 2 of the conventional actin subunit and subdomain 1 of the adjacent subunit in the actin filament. The 
residues in actin which bind to the spectrin superfamily of proteins are conserved  in the primary sequence  of centractin (reviewed  in 
Hartwig, 1994; reviewed in Matsudaira,  1994). 
rected against either the p150  Glued or centractin subunits of 
dynactin (Fig. 9 b, lane 1). Control precipitates with pro- 
tein A  agarose beads showed no significant reactivity with 
antibodies to centractin, p150  clued, actin, spectrin, or addu- 
cin (Fig. 9 b, lane 2). In addition to the monoclonal anti- 
spectrin AA6 antibody, we also probed the immunopre- 
cipitates with other spectrin antibodies: a monoclonal anti- 
body to the spectrin isoform, 13IEI (Harris et al., 1986) and 
a  polyclonal  spectrin  antibody,  MH-1  9B  (Black  et  al., 
1988).  These antibodies all recognized similar sized bands 
slightly above the 212-kD molecular weight marker (Fig. 9 
c). The  results  of the  immunoprecipitations indicate  that 
spectrin, adducin, and dynactin associate. 
Affinity Chromatography Also Demonstrates an 
Interaction between Dynactin and Spectrin 
Previously we have shown that the dynactin complex can 
be retained  on  a  column  of CH-Sepharose beads  cross- 
linked to the dynein intermediate chain (DIC; Karki and 
Holzbaur, 1995). In this study we observed that in addition 
to the elution of dynactin components from a DIC column, 
spectrin also co-elutes (Fig. 10, a  and b). These results in 
conjunction  with  the  immunoprecipitations  described 
above reveal that dynactin and spectrin associate. Affinity 
chromatography of dynactin also demonstrates that actin 
does not co-elute consistently with the complex (data not 
shown).  Our  set  of experiments excludes  the  possibility 
that conventional actin is a bona fide dynactin component 
in contrast to the results of Schafer et al. (1994). 
Taken  together,  our  data  demonstrate  that  centractin 
can form novel filamentous structures in transfected cells 
which  are  distinct  from  conventional  actin  filaments  in 
composition,  morphology  and  pharmacology,  as  deter- 
mined by a resistance to cytochalasin D  and an inability to 
bind  phalloidin.  These  filaments  colocalize  with  Golgi 
membrane markers and Golgi-spectrin. Analysis of cellu- 
lar fractions enriched for dynactin revealed that spectrin 
comigrates with dynactin and affinity chromatography and 
coimmunoprecipitations  demonstrate  an  association  be- 
tween spectrin, adducin, and the dynactin complex. 
Discussion 
Centractin has been identified  as a member of a growing 
family of actin-related proteins. Centractin shares 53% iden- 
tity with conventional actin and forms a 37-nm filament of 
apparently invariant length in the context of native dynac- 
tin. The ultrastructure of this centractin mini-filament re- 
veals similarity to actin and indicates that centractin can 
self associate  to  form  a  polymer of 8  to  13  monomers 
(Schafer et al., 1994).  Our transient transfection studies 
revealed that centractin  can form novel macromolecular 
filaments of varying lengths (0.62-22 Ixm), if the protein is 
expressed significantly above normal cellular levels. The 
difference in lengths suggests that the mechanism of length 
regulation is not inherent to the centractin molecule. The 
length  regulation,  whether  it is due  to an association of 
"ruler proteins" or other processes, is therefore not tightly 
coupled  to  the  overexpression of centractin  protein.  At 
this  time, we cannot  distinguish  whether  these  filaments 
are extended polymers, bundles, or associations of shorter 
centractin  filaments.  Further  analysis using  electron  mi- 
croscopy to examine thin sections may clarify these possi- 
bilities. However, we have excluded the possibility that the 
formation of the centractin filaments in transfected cells is 
due to copolymerization with actin. The integrity of these 
filaments is also independent of an association with a tubu- 
lovesicular membrane template, and is not due to the se- 
questration of the overexpressed protein in the Golgi ap- 
paratus. 
The  pharmacological  properties  and  cellular  distribu- 
tion of the novel centractin filaments in transfected cells 
indicate  that  F-actin  and  centractin  do  not  incorporate 
into a  common structure.  It has been reported that cen- 
tractin synthesized in an in vitro transcription/translation 
system was observed to copellet with F-actin in a cosedi- 
mentation assay (Melki  et al.,  1993).  It is unclear  if this 
cosedimentation reflects a direct association or if it is me- 
diated  by other proteins present within  the reticulocyte 
lysate. In our transient transfection assays, the centractin 
filaments do not colocalize with actin, do not bind phalloi- 
din, and  are not disrupted  by cytochalasin D. While it is 
possible that actin and centractin may interact in vivo by a 
lateral  or capping association which  might be below the 
limits of detection  of our transfection  assay, our results 
demonstrate  that in  transfected cells overexpressed cen- 
tractin  and  endogenous  actin  do  not  copolymerize to  a 
measurable extent. Even in experiments where we disrupt 
the filamentous actin with cytochalasin D  and then allow 
the F-actin to reform, we observe no coincorporation of 
actin into  the novel centractin  filaments or of centractin 
into the reforming F-actin. We cannot exclude the possi- 
bility that the novel centractin filaments may be stable in 
the presence of cytochalasin D  possibly because they are 
capped at both ends. 
Biochemical analysis revealed that actin was absent from 
immunoprecipitations of the dynactin complex which  ef- 
fectively concentrate the dynactin complex subunits from 
cytosol. Actin  is also absent from dynactin preparations 
purified by affinity chromatography. These results contra- 
dict a previous study which reported that conventional ac- 
tin is a bonafide component of dynactin (Schafer et al., 1994). 
We suggest that actin is not an integral subunit of dynactin. 
Instead, actin may be more loosely associated with dynactin, 
potentially through a link mediated by other polypeptides. 
Holleran et al. Cellular Association of Dynactin and Spectrin  1823 Figure 7.  Epifluorescence micrographs demonstrating the colocalization of spectrin and Golgi-spectrin (13IE*) with centractin filaments 
in transfected ceils. Ceils were processed for IMF after fixation in 1 mM EGTA in MeOH. (a and b) Double-label immunocytochemis- 
try using the anti-centractin antibody UPGP21 and the anti-Golgi specific antibody, 13IE*, reveals the colocalization of centractin (a) 
with Golgi-specific  spectrin (b) in untransfected cells. Analysis of transfected cells using the anti-centractin antibody, UPGP21 (c and e), 
and the antibody to the Golgi-specific  spectrin, [3IE* (b and d), reveals that the two proteins colocalize in transfected cells. Analysis of 
transfected cells using anti-centractin UP385 antibodies (g) and a broad range of anti-non-erythroid spectrin isoform antibody, AA6 (h) 
also demonstrates an association of overexpressed centractin polypeptide with non-erythroid spectrin. Bar, 5 ~xM. Figure 8.  Spectrin is present in fractions in which dynactin is en- 
riched and comigrates with dynactin fractions on a sucrose gradi- 
ent. (A) Protein samples of cellular fractions  were resolved on a 
7% SDS-PAGE gel, electroblotted  to Immobilon, and stained with 
Coomassie. Lanes: (1) Whole brain extract,  (2) brain cytosol, (3) 
ATP extract,  (4) NaC1 extract.  (B) Corresponding immunoblots 
of the blot shown in A probed with two anti-spectrin  antibodies, 
AA6 and MHd 9B, anti-pl50  ~tued antibody UP235 and anti-cen- 
tractin  antibody,  UP454. (C) Coomassie stained blot of ATP ex- 
tract of microtubules  fractionated over a 5-20% sucrose gradient. 
(D) Corresponding immunoblot in C probed with  antibodies to 
spectrin (AA6 and MH-1 9B) and centractin (UP385). While  the 
peak of spectrin is in fractions 6-8, there is a considerable  amount 
of spectrin that comigrates with the dynactin complex in fractions 
4  and  5.  Although  our  antibodies  to  centractin  (UP454  and 
UP385)  lack  the  sensitivity  to  recognize  centractin within  the 
whole brain extract and the cytosol, these two antibodies  recog- 
nize centractin when it is concentrated in the ATP and high salt 
extracts of taxol-stabilized  microtubules  prepared from rat brain 
cytosol (B, lanes 3 and 4). 
In this study we have observed that in cells transfected 
with centractin,  the  Golgi is disrupted.  These results are 
intriguing  since  dynactin  appears to  play  a  fundamental 
role in the processes of nuclear migration and vesicle mo- 
tility in conjunction with cytoplasmic dynein (reviewed in 
Holzbaur and Vallee, 1994; Sweeney and Holzbaur, 1996). 
The colocalization of Golgi marker proteins with centrac- 
tin filaments revealed that in many transfected cells the or- 
ganelle becomes elongated in contrast to the normal punc- 
tate perinuclear distribution of the Golgi in untransfected 
control cells. In other transfected cells, the Golgi appears 
to be fragmented and associated with numerous short cen- 
tractin  filaments. We  suggest that  as overexpressed cen- 
tractin forms a filament, fragmented Golgi vesicles are re- 
cruited along its length. This would result in "stretching" 
the Golgi along the side of the forming filament. We spec- 
ulate that the difference in morphology in transfected cells 
may be due to differences in the status of the Golgi at the 
time  of centractin  overexpression.  The  Golgi  apparatus 
becomes disrupted  during  mitosis  and  is  then  reformed 
during interphase (Lucocq et al., 1989). It may be that the 
cells with shorter filaments were transfected after cell divi- 
sion  and  the  overexpressed centractin  filaments become 
associated  with  Golgi  elements,  disrupting  the  reforming 
Golgi stacks. 
The transfection results revealing Golgi disruption and 
colocalization of Golgi markers with centractin, the struc- 
ture of the centractin mini-filament within the native dy- 
nactin  complex and  the  primary sequence  of centractin, 
led us to look for potential mediator proteins, like spectrin, 
in this association of centractin with the Golgi organelle. 
In non-erythroid cells spectrin is thought to play a role 
in  membrane compartmentalization  and  sorting through 
the differential localization of functionally specific isoforms 
(reviewed in Goodman et al., 1988; Winkelmann and For- 
get, 1993). The [3 non-erythroid spectrins are not as highly 
conserved  as  the  et  spectrins  in  sequence  and  structure 
(Dubreuil  et al.,  1989;  Wasenius  et al.,  1989;  Sahr et al., 
1990),  and this diversity has been implicated in the func- 
tional  specialization  of individual  spectrin  subtypes.  For 
example, in addition  to the identification of a  Golgi-spe- 
cific 13-spectrin  isoform (Beck  et  al.,  1994),  spectrin  iso- 
forms expressed in the brain are associated with "distinct" 
cytoplasmic organelles and membrane compartments (Laz- 
erides and Nelson, 1983; Zagon et al., 1986).  Assigning dis- 
tinct subtypes of spectrins to different membrane popula- 
tions would allow directed vesicle trafficking within the cell. 
Zagon et al. (1986) have determined that in brain, a tissue 
in which dynactin is highly enriched (Melloni et al., 1995), 
spectrin localizes to the plasma membrane, the cytoplasmic 
surface of the ER, the nuclear envelope, the mitochondria, 
in the cytoplasm of neuronal soma and dendrites and the 
glial cell body, and synaptic vesicles. Spectrin which is as- 
sociated with intracellular organelles may play an important 
role in axonal organelle and vesicle transport possibly by 
linking membrane proteins and soluble proteins to the mi- 
crotubules and aiding in their transport (Fach et al., 1985). 
Within the membrane network of erythrocyte and non- 
erythrocyte cells, spectrin associates with short actin oligo- 
mers of 10--14 subunits in length (for review see Hartwig, 
1994). Primary sequence analysis indicates that those resi- 
dues  in  actin  which  have  been  shown  to  participate  in 
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ates with dynactin. (A) Protein samples were resolved on a 7% 
SDS-PAGE gel,  electroblotted to Immobilon, and stained with 
Coomassie blue. Lanes: (1) rat brain cytosol, (2) the flow-through 
of the DIC column, (3) the final wash fraction before elution, (4) 
the 1 M NaCI eluate of the DIC column, (5) the flow-through of 
the BSA control column, (6) the final wash fraction before elution, 
and (7) 1 M eluate of the BSA control column. (B) Correspond- 
ing immunoblots of A probed with antibodies to spectrin (AA6), 
p1506tued (UP235), centractin (UP454) demonstrating an associa- 
tion between spectrin and dynactin. 
Figure 9.  Spectrin  coprecipitates  with the dynactin complex under 
nondenaturing conditions. (A) Protein samples of immunoprecip- 
itations from rat brain cytosol were resolved  on a 7% SDS-PAGE 
gel, electroblotted  to Immobilon, and stained  with Coomas- 
sie  blue. Lanes: (1)  Rat brain cytosol before immunoprecipita- 
tion; (2) control precipitation with protein A-agarose with no an- 
tibody  bound;  (3)  immunoprecipitation  with  anti-centractin 
antibody UP454; (4) immunoprecipitation  with anti-pl50  a;u~d anti- 
body UP235. (B) Corresponding immunoblots of the blot shown 
in A probed with antibodies to spectrin, p150 c;ued, adducin, cen- 
tractin,  and conventional actin. These immunoprecipitations dem- 
onstrate  that the dynactin complex coprecipitates with spectrin 
and et adducin. In contrast, actin was not observed in the immu- 
noprecipitate. Although our antibodies to centractin (UP454 and 
UP385) lack the sensitivity  to recognize centractin within  the cy- 
tosol, these two antibodies recognize centractin when it is con- 
centrated  in  extracts,  such  as  recombinant  purified  centractin 
(Fig. 3 C, lane 2), a high salt  extract of taxol-stabilized  microtu- 
bules prepared from rat brain cytosol (Fig.  1 c, lane 3 and Fig. 8 
B, lane 4) or in an immunoprecipitate with antibodies to dynactin 
subunits (Fig. 9 B, lanes 3 and 4). (C) Immunoblots of the immu- 
noprecipitated samples,  UP454 (left lane) and UP235 (right lane) 
were  probed with  three  independent  anti-sera  to spectrin,  (1) 
AA6 monoclonal antibody,  (2)  anti-spectrin  antibody,  VIIIC7 
(Harris et al., 1986), and (3) polyclonal anti-spectrin MH-1 9B an- 
spectrin binding (reviewed by Hartwig,  1994; Matsudaira, 
1994) are conserved in centractin  (Fig. 6).  Stoichiometric 
analysis of purified dynactin complex has led to estimates 
of between  8  and  13 subunits  of centractin  per mini-fila- 
ment (Gill et al.,  1991; Paschal et al.,  1993; Schafer et al., 
1994)  and structural  analysis of dynactin reveals  that  the 
37-nm centractin filament resembles  actin (Schafer et  al., 
1994)  and can be  compared  to the short  actin  oligomers 
that associate with spectrin in the membrane. In this study 
we demonstrate that Golgi-spectrin (13IE*)  and centractin 
colocalize in  transfected  cells.  The  colocalization of cen- 
tractin  with  spectrin  observed  by  immunocytochemistry 
combined with the comigration of dynactin and spectrin in 
dynactin preparations, affinity chromatography, and coim- 
munoprecipitations of these two polypeptides suggest that 
spectrin may associate with dynactin via the centractin fila- 
ment of the complex. With the results of our study, we sug- 
gest a model for an association of dynactin with the vesicle. 
We are now designing experiments  to probe for direct 
binding between  spectrin  and centractin,  but we propose 
that the attachment of dynactin to the membrane cargo in 
interphase cells may be mediated by the short 37-nm cen- 
tractin filament in native dynactin through an interaction 
with a  spectrin meshwork  associated  with  the membrane 
of the  Golgi organelle.  Because  spectrin  has  many func- 
tionally distinct  subunit  types  and  splice  forms  and  cen- 
tibody (Black et al., 1988). All three anti-spectrin antibodies rec- 
ognize a  similar  protein band migrating just  above the 212-kD 
marker confirming that the  band recognized by the AA6 anti- 
body is indeed spectrin. 
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Figure 11.  Model depicting  the interaction of dynactin  with the 
organelle based on (1) the conservation in structure of the cen- 
tractin  mini-filament  in  the  native dynactin  complex with  the 
short actin mini-filaments  that associate with spectrin in erythro- 
cyte cells, (2) the conservation of the spectrin-binding  site in con- 
ventional actin with the centractin sequence,  (3) the colocaliza- 
tion  of spectrin  and  Golgi protein  antibodies  with  centractin 
antibodies using immunocytochemistry,  and (4) the affinity chro- 
matography of dynactin  in conjunction  with the coimmunopre- 
cipitation of spectrin and adducin in the absence of actin. We pro- 
pose that the centractin mini-filament  of the dynactin  complex 
incorporates into  the  spectrin-membrane associated  cytoskele- 
ton.  The attachment of centractin to spectrin  may be strength- 
ened by proteins such as adducin (as denoted by the hatched cir- 
cle).  The  specificity  of targeting of dynactin  to organelles  for 
minus end directed transport along microtubules driven by cyto- 
plasmic dynein may be mediated by organelle-specific isoforms of 
membrane cytoskeletal linker proteins such as spectrin, ankyrin, 
or adducin which may then associate with an integral  membrane 
protein (denoted by the black box). Additional proteins may also 
be involved  but are not shown.  Plasma membrane-specific iso- 
forms of spectrin may mediate a similar type of attachment of dy- 
nactin  to the cell membrane. This association  might anchor dy- 
nactin  and dynein to the cortex and allow dynein  to produce a 
force on the cell microtubules of the mitotic apparatus during cell 
division.  (Dynactin  in  the  model  is  adapted  from  Karki  and 
Holzbaur, 1995.) 
tractin  has at least two isoforms (Clark et al.,  1994),  we 
suggest that the association of centractin with the Golgi in 
transfected  cells  may  be  mediated  by  a  non-erythroid 
spectrin isoform which can associate with the Golgi mem- 
brane as well as interact with centractin. A candidate is the 
recently characterized  Golgi-spectrin (13I~*,  Beck  et al., 
1994).  In this way, like erythroid spectrin, which secures 
the spectrin-actin scaffold to the plasma membrane in red 
blood cells  (Morrow,  1989;  Bennett,  1990),  an organelle 
specific isoform of spectrin may link centractin and there- 
fore dynactin to the membrane of the Golgi (Fig. 11). It re- 
mains to be determined if other proteins would mediate or 
reinforce the association of dynactin with the Golgi and/or 
other cellular organelles. Using immunoprecipitations, we 
show that a-adducin, in addition to spectrin, coprecipitates 
with the dynactin complex. Erythrocyte adducin promotes 
spectrin-actin  binding  in  vitro  (Gardner  and  Bennett, 
1986; Li and Bennett, 1996). In non-erythrocyte cells, addu- 
cin has multiple isoforms that vary in their associations and 
properties (Joshi et al., 1990; Bennett et al., 1988; Waseem 
and Palfrey, 1990). The complexity of adducin isoforms and 
subunit  associations makes it  tempting  to  speculate  that 
there may exist an isoform specific for promoting an asso- 
ciation between dynactin and spectrin and a membrane re- 
ceptor. The identification of multiple isoforms of [3-spec- 
trin,  ~  and  13 centractin  isoforms, and isoforms of other 
proteins such as adducin suggests that together these inter- 
actions can provide multiple combinations and may be im- 
portant for vesicle targeting and sorting and Golgi mainte- 
nance  by motor proteins  and  their  associated  accessory 
complexes such as dynactin. 
Mutations  in  subunits  of either  dynein  or  dynactin in 
yeast, Aspergillus, Neurospora, and cultured cells have in- 
dicated  a  role  for these  complexes in  nuclear  migration 
and spindle maintenance during mitosis (Eshel et al., 1993; 
Li et al.,  1993;  Muhua  et al.,  1994;  Plamann et al.,  1994; 
Xiang et al., 1994; Saunders et al., 1995; Yeh et al., 1995). 
Overexpression of the dynactin subunit,  p50,  resulted  in 
aberrant spindle pole formation in some transfected cells 
(Echeverri  et al.,  1996).  Vaisberg et al.  (1993)  observed 
that micro-injection of antibodies raised against the ATP- 
binding site of the cytoplasmic dynein heavy chain led to a 
collapse of the interpolar distance of the spindle. These 
results demonstrate that dynein and dynactin may be in- 
volved in the maintenance of centrosome separation early 
in  mitosis.  A  minus-end  directed  motor such  as  dynein 
may contribute to spindle pole separation by providing a 
pulling force via the astral microtubules from an anchor- 
age in the cell cortex (Vaisberg et al., 1993; Waters et al., 
1993).  In this model, the tethering of dynein to the cortex 
would provide support for the motor so that an effective 
pulling force could be produced on the microtubules of the 
spindle  apparatus.  Such  an  interaction  between  dynein 
and the cell cortex may be mediated by dynactin. We pro- 
pose that in a manner similar to our model for the associa- 
tion of dynactin with the vesicle (Fig.  11),  dynactin may 
also associate with the plasma membrane via the incorpo- 
ration  of the  centractin  mini-filament into  a  membrane- 
associated  spectrin  meshwork.  In  this  manner,  dynactin 
would link dynein to the cell cortex while allowing it to inter- 
act with the microtubules emanating from the spindle poles. 
In summary, when expressed significantly above endog- 
enous  levels,  centractin  can  form filamentous  structures 
within the cell. Actin is not coincorporated into the centrac- 
tin filaments, and the novel filaments are pharmacologi- 
cally distinct from F-actin. The cellular analysis of centrac- 
tin in transfected cells coupled with biochemical analysis 
using sucrose gradients, immunoprecipitations, and affin- 
ity chromatography has yielded results which enable us to 
propose a specific mechanism for dynactin attachment to the 
vesicle/membrane. While it has been speculated that both 
dynactin and dynein may be linked to the vesicle via a cy- 
toskeletal membrane-associated network (Vallee and Sheetz, 
1996),  our  study  provides  the  first  specific evidence  for 
such an interaction. We suggest that association of the dy- 
nactin complex with its membrane target can be mediated 
by spectrin,  possibly by incorporation of the 37-nm cen- 
tractin filament within the complex into the spectrin net- 
work that associates with membranes and vesicles. In this 
model, centractin would serve as the structural element of 
dynactin that links dynactin to its membrane target or ves- 
icle cargo. 
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